Your institution may have access to this item. Find your institution then sign in to continue.
Title
Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections
Authors
Committee on Infectious Diseases and Committee on Fetus and Newborn